FDA Import Refusal AEK-9175547-8/10001/1 — LILLY CORPORATE CENTER
The FDA refused shipment AEK-9175547-8/10001/1 from LILLY CORPORATE CENTER (United States) on Jan 18, 2026. The refused product falls under Drugs and Biologics — TIRZEPATIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 3 other import refusals on record.
Refusal Details
- Date
- Jan 18, 2026
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61PCL74 TIRZEPATIDE (ANTI-DIABETIC)
- Charges
- 75